Nitroreductase
From Proteopedia
(Difference between revisions)
Line 24: | Line 24: | ||
**[[1nec]], [[1kqd]] – EclNR – ''Enterobacter cloacae''<br /> | **[[1nec]], [[1kqd]] – EclNR – ''Enterobacter cloacae''<br /> | ||
**[[1ywq]], [[2i7h]] – NR – ''Bacillus cereus''<br /> | **[[1ywq]], [[2i7h]] – NR – ''Bacillus cereus''<br /> | ||
+ | **[[5hdj]] – NR – ''Bacillus megaterium''<br /> | ||
**[[2b67]] – NR – ''Streptococcus pneumonia''<br /> | **[[2b67]] – NR – ''Streptococcus pneumonia''<br /> | ||
**[[3ek3]], [[3hoi]] – NR – ''Bacterioides fragilis''<br /> | **[[3ek3]], [[3hoi]] – NR – ''Bacterioides fragilis''<br /> | ||
Line 49: | Line 50: | ||
**[[4bn9]] – LlNR + nicotinic acid<br /> | **[[4bn9]] – LlNR + nicotinic acid<br /> | ||
**[[4bnb]] – LlNR + nitroquinoline<br /> | **[[4bnb]] – LlNR + nitroquinoline<br /> | ||
+ | |||
+ | *Nitrobenzoate nitroreductase | ||
+ | |||
+ | **[[4z85]] – NR – ''Psudomonas fluorescens''<br /> | ||
*Nitroreductase binary complex | *Nitroreductase binary complex | ||
Line 59: | Line 64: | ||
**[[1oo6]], [[1oon]], [[1idt]] – EcNR + benzamide derivative<br /> | **[[1oo6]], [[1oon]], [[1idt]] – EcNR + benzamide derivative<br /> | ||
**[[1yki]] – EcNR + antibiotic<br /> | **[[1yki]] – EcNR + antibiotic<br /> | ||
- | **[[2wzw]] - MsNR + NADPH | + | **[[2wzw]] - MsNR + NADPH<br /> |
+ | **[[6czp]] – NR + FMN – ''Vibrio vulnificus''<br /> | ||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 07:29, 15 August 2018
|
3D structures of nitroreductase
Updated on 15-August-2018
References
- ↑ Lovering AL, Hyde EI, Searle PF, White SA. The structure of Escherichia coli nitroreductase complexed with nicotinic acid: three crystal forms at 1.7 A, 1.8 A and 2.4 A resolution. J Mol Biol. 2001 May 25;309(1):203-13. PMID:11491290 doi:10.1006/jmbi.2001.4653
- ↑ Williams EM, Little RF, Mowday AM, Rich MH, Chan-Hyams JV, Copp JN, Smaill JB, Patterson AV, Ackerley DF. Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility. Biochem J. 2015 Oct 15;471(2):131-53. doi: 10.1042/BJ20150650. PMID:26431849 doi:http://dx.doi.org/10.1042/BJ20150650